Does MECASERMIN Cause Tonsillar hypertrophy? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Tonsillar hypertrophy have been filed in association with MECASERMIN (GUNA-IGF). This represents 4.6% of all adverse event reports for MECASERMIN.
22
Reports of Tonsillar hypertrophy with MECASERMIN
4.6%
of all MECASERMIN reports
0
Deaths
7
Hospitalizations
How Dangerous Is Tonsillar hypertrophy From MECASERMIN?
Of the 22 reports, 7 (31.8%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Tonsillar hypertrophy Listed in the Official Label?
Yes, Tonsillar hypertrophy is listed as a known adverse reaction in the official FDA drug label for MECASERMIN.
What Other Side Effects Does MECASERMIN Cause?
Off label use (117)
Headache (41)
Hypoglycaemia (36)
Blood glucose decreased (32)
Drug dose omission (27)
Injection site pain (26)
Vomiting (26)
Fatigue (25)
Pyrexia (23)
Decreased appetite (22)
What Other Drugs Cause Tonsillar hypertrophy?
ADALIMUMAB (151)
ONDANSETRON (51)
SOMATROPIN (43)
SECUKINUMAB (42)
DUPILUMAB (39)
METHOTREXATE (39)
INFLIXIMAB (31)
TACROLIMUS (26)
INFLIXIMAB-DYYB (25)
ETANERCEPT (24)
Which MECASERMIN Alternatives Have Lower Tonsillar hypertrophy Risk?
MECASERMIN vs MECHLORETHAMINE
MECASERMIN vs MECLIZINE
MECASERMIN vs MEDROL
MECASERMIN vs MEDROXYPROGESTERONE
MECASERMIN vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE